Memory Losses Completed Phase 1 Trials for Midazolam (DB00683)

Also known as: Memory Loss / Loss of memory / Amnesia / Amnesia NOS / Memory loss of

IndicationStatusPhase
DBCOND0031656 (Memory Losses)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00142493Effect of Affective Content on Drug Induced Amnesia of Episodic MemoryTreatment